ES2303653T3 - Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio. - Google Patents

Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio. Download PDF

Info

Publication number
ES2303653T3
ES2303653T3 ES04817576T ES04817576T ES2303653T3 ES 2303653 T3 ES2303653 T3 ES 2303653T3 ES 04817576 T ES04817576 T ES 04817576T ES 04817576 T ES04817576 T ES 04817576T ES 2303653 T3 ES2303653 T3 ES 2303653T3
Authority
ES
Spain
Prior art keywords
alkyl
alkyloxy
mono
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES04817576T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Francois Bonfanti
Koenraad Jozef Lodewijk Andries
Jerome Michel Claude Fortin
Philippe Muller
Frederic Marc Maurice Doublet
Christophe Meyer
Rudy Edmond Willebrords
Tom Valerius Josepha Gevers
Philip Maria Martha Bern Timmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen R&D Ireland ULC
Original Assignee
Tibotec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34704695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2303653(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharmaceuticals Ltd filed Critical Tibotec Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2303653T3 publication Critical patent/ES2303653T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES04817576T 2003-12-18 2004-12-20 Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio. Active ES2303653T3 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP03104810 2003-12-18
EP03104810 2003-12-18
US56718204P 2004-04-30 2004-04-30
US567182P 2004-04-30
EP04105312 2004-10-26
EP04105312 2004-10-26

Publications (1)

Publication Number Publication Date
ES2303653T3 true ES2303653T3 (es) 2008-08-16

Family

ID=34704695

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04817576T Active ES2303653T3 (es) 2003-12-18 2004-12-20 Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio.

Country Status (33)

Country Link
US (2) US7449463B2 (da)
EP (1) EP1697345B1 (da)
JP (1) JP4951348B2 (da)
KR (1) KR100967406B1 (da)
CN (2) CN1894237A (da)
AP (1) AP2150A (da)
AR (1) AR046959A1 (da)
AT (1) ATE388950T1 (da)
AU (1) AU2004298460B2 (da)
BR (1) BRPI0417268B8 (da)
CA (1) CA2548668C (da)
CY (1) CY1108142T1 (da)
DE (1) DE602004012448T2 (da)
DK (1) DK1697345T3 (da)
EA (1) EA009876B1 (da)
EG (1) EG25799A (da)
ES (1) ES2303653T3 (da)
HK (1) HK1130799A1 (da)
HR (1) HRP20080245T3 (da)
IL (1) IL175910A (da)
ME (1) ME01042B (da)
MX (1) MXPA06007112A (da)
MY (1) MY143573A (da)
NO (1) NO339314B1 (da)
NZ (1) NZ547479A (da)
PL (1) PL1697345T3 (da)
PT (1) PT1697345E (da)
RS (1) RS50584B (da)
SI (1) SI1697345T1 (da)
TW (1) TWI351401B (da)
UA (1) UA84718C2 (da)
WO (1) WO2005058871A1 (da)
ZA (1) ZA200605894B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
TWI370820B (en) 2005-04-27 2012-08-21 Takeda Pharmaceutical Fused heterocyclic compounds
AU2006260969B2 (en) * 2005-06-20 2011-11-17 Janssen Sciences Ireland Uc 1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) -3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
CA2612264C (en) * 2005-06-20 2014-09-23 Tibotec Pharmaceuticals Ltd. Heterocyclylaminoalkyl substituted benzimidazoles
US20120148678A1 (en) 2010-12-08 2012-06-14 Advanced Technologies And Regenerative Medicine, Llc. Sustained release of poorly water soluble active compounds
PT2766359T (pt) 2011-10-14 2016-07-14 Ambit Biosciences Corp Compostos heterocíclicos e utilização dos mesmos como moduladores de recetores tirosina-cinase de tipo iii
UA119050C2 (uk) * 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
JO3637B1 (ar) * 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
CN109562160B (zh) * 2016-05-10 2022-07-29 乔治亚州立大学研究基金会股份有限公司 用于治疗rsv的双环稠合的吡唑衍生物
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
RS60209B1 (sr) 2017-03-20 2020-06-30 Forma Therapeutics Inc Kompozicije pirolopirola kao aktivatori piruvat kinaze (pkr)
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗rsv活性之吡唑并嘧啶
JP7305658B2 (ja) 2018-01-31 2023-07-10 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗rsv活性を有するシクロアルキル置換ピラゾロピリミジン
WO2019206828A1 (en) 2018-04-23 2019-10-31 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against rsv
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r
US20220031671A1 (en) 2018-09-19 2022-02-03 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
GB201820751D0 (en) * 2018-12-19 2019-01-30 Bp Oil Int Methods for preparing intermediates
BR112022001125A2 (pt) 2019-07-22 2022-03-15 Lupin Ltd Compostos macrocíclicos como agonistas de sting, seus métodos e seus usos
JP7329239B2 (ja) 2019-09-20 2023-08-18 株式会社タマディック フライトシミュレーター
WO2023018560A1 (en) * 2021-08-13 2023-02-16 Georgia State University Research Foundation, Inc. Bicyclic fused pyrazole derivatives for the treatment of respiratory infections including rsv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20014574A3 (cs) * 1999-06-28 2002-05-15 Janssen Pharmaceutica N. V. Inhibitory replikace respiračně syncyciálního viru
DE60033859T2 (de) * 1999-06-28 2007-11-08 Janssen Pharmaceutica N.V. Hemmer des Respiratorischen Syncytial Virus
AU778218B2 (en) * 1999-06-28 2004-11-25 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
AR046971A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio

Also Published As

Publication number Publication date
ATE388950T1 (de) 2008-03-15
US20080280881A1 (en) 2008-11-13
CN101412709A (zh) 2009-04-22
CA2548668C (en) 2011-09-20
KR100967406B1 (ko) 2010-07-01
IL175910A (en) 2013-08-29
BRPI0417268A (pt) 2007-03-13
EA200601178A1 (ru) 2006-10-27
JP2007514720A (ja) 2007-06-07
NO20063322L (no) 2006-09-18
AP2006003640A0 (en) 2006-06-30
RS50584B (sr) 2010-05-07
ME01042B (me) 2012-10-20
MXPA06007112A (es) 2006-08-23
MY143573A (en) 2011-05-31
US7449463B2 (en) 2008-11-11
NZ547479A (en) 2009-03-31
PT1697345E (pt) 2008-06-12
IL175910A0 (en) 2006-10-05
CA2548668A1 (en) 2005-06-30
EP1697345B1 (en) 2008-03-12
DK1697345T3 (da) 2008-06-23
EG25799A (en) 2012-08-06
HK1130799A1 (en) 2010-01-08
KR20070015507A (ko) 2007-02-05
TW200531972A (en) 2005-10-01
US8883837B2 (en) 2014-11-11
BRPI0417268B8 (pt) 2021-05-25
WO2005058871A1 (en) 2005-06-30
DE602004012448D1 (de) 2008-04-24
AR046959A1 (es) 2006-01-04
BRPI0417268B1 (pt) 2018-10-23
NO339314B1 (no) 2016-11-28
AU2004298460A1 (en) 2005-06-30
US20070043022A1 (en) 2007-02-22
ZA200605894B (en) 2008-01-08
DE602004012448T2 (de) 2009-03-26
JP4951348B2 (ja) 2012-06-13
CY1108142T1 (el) 2014-02-12
AP2150A (en) 2010-09-04
AU2004298460B2 (en) 2009-03-19
EP1697345A1 (en) 2006-09-06
PL1697345T3 (pl) 2008-08-29
CN101412709B (zh) 2015-03-25
HRP20080245T3 (en) 2008-07-31
SI1697345T1 (sl) 2008-08-31
TWI351401B (en) 2011-11-01
EA009876B1 (ru) 2008-04-28
CN1894237A (zh) 2007-01-10
UA84718C2 (ru) 2008-11-25

Similar Documents

Publication Publication Date Title
ES2303653T3 (es) Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio.
KR101074334B1 (ko) 호흡기 세포융합 바이러스 복제 저해제로서의피페리딘-아미노-벤즈이미다졸 유도체
ES2328700T3 (es) Aminobenzimidazoles y benzimidazoles como inhibidores de la replicacion del virus respiratorio sincital.
CA2612263C (en) 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
ES2326813T3 (es) Derivados de amino-bencimidazoles como inhibidores de la replicacion del virus respiratorio sincitial.
US8178694B2 (en) Heterocyclylaminoalkyl substituted benzimidazoles
MXPA06007111A (es) Derivados bencimidazol 5- o 6-sustituidos como inhibidores de la replicacion del virus sincitial respiratorio.
ES2392863T3 (es) Bencimidazoles 2-sustituidos
MXPA06007108A (es) Aminobencimidazoles y bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio.